TY - JOUR
T1 - En bloc resection for nonmuscle-invasive bladder cancer
T2 - selecting a proper laser
AU - Enikeev, Professor Dmitry
AU - Babjuk, Marek
AU - Shpikina, Anastasia
AU - Shariat, Shahrokh
AU - Glybochko, Petr
N1 - Publisher Copyright:
Copyright ß 2021 Wolters Kluwer Health, Inc. All rights reserved.
PY - 2022/3/1
Y1 - 2022/3/1
N2 - Purpose of review To discuss the most recent surgical lasers that have been made available to us and to evaluate their potential in performing en bloc resection of nonmuscle invasive bladder cancer. Recent findings Laser en bloc resection of bladder tumors (ERBT) can be performed with a number of laser systems including Ho:YAG, GreenLight, diode, Tm:YAG and thulium fiber lasers (TFL). The data that is currently available suggests that the water-targeting devices (utilizing water as a primary chromophore – Ho:YAG, Tm:YAG, TFL) may have a number of advantages over hemoglobin-targeting systems (potassium titanyl phosphate:YAG, lithium triborate:YAG). One recent addition to the surgical armamentarium Moses effect enhanced Ho:YAG and the TFL (being able to work both in quasi-continuous and SuperPulsed modes) necessitates careful discussion and comparison with the other available devices. Summary The majority of available lasers have proven to be safe to use and compared to electrocautery allow for lower rates of obturator nerve reflex and result in fewer bleeding complications. The minimal penetration depth and decreased peak power of Tm:YAG and TFLs render them the devices of choice when it comes to ERBT. Unfortunately, more studies on ERBT with TFL are needed in order for us to make a sound assessment of the respective pros and cons.
AB - Purpose of review To discuss the most recent surgical lasers that have been made available to us and to evaluate their potential in performing en bloc resection of nonmuscle invasive bladder cancer. Recent findings Laser en bloc resection of bladder tumors (ERBT) can be performed with a number of laser systems including Ho:YAG, GreenLight, diode, Tm:YAG and thulium fiber lasers (TFL). The data that is currently available suggests that the water-targeting devices (utilizing water as a primary chromophore – Ho:YAG, Tm:YAG, TFL) may have a number of advantages over hemoglobin-targeting systems (potassium titanyl phosphate:YAG, lithium triborate:YAG). One recent addition to the surgical armamentarium Moses effect enhanced Ho:YAG and the TFL (being able to work both in quasi-continuous and SuperPulsed modes) necessitates careful discussion and comparison with the other available devices. Summary The majority of available lasers have proven to be safe to use and compared to electrocautery allow for lower rates of obturator nerve reflex and result in fewer bleeding complications. The minimal penetration depth and decreased peak power of Tm:YAG and TFLs render them the devices of choice when it comes to ERBT. Unfortunately, more studies on ERBT with TFL are needed in order for us to make a sound assessment of the respective pros and cons.
KW - Bladder cancer
KW - En bloc
KW - Laser
KW - Nonmuscle invasive bladder cancer
KW - Resection
UR - http://www.scopus.com/inward/record.url?scp=85123901682&partnerID=8YFLogxK
U2 - 10.1097/MOU.0000000000000968
DO - 10.1097/MOU.0000000000000968
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.systematicreview???
C2 - 34954702
AN - SCOPUS:85123901682
SN - 0963-0643
VL - 32
SP - 173
EP - 178
JO - Current Opinion in Urology
JF - Current Opinion in Urology
IS - 2
ER -